Abuhatzira Liron, Xu Huanyu, Tahhan Georges, Boulougoura Afroditi, Schäffer Alejandro A, Notkins Abner L
*Experimental Medicine Section, Laboratory of Sensory Biology, National Institute of Dental and Craniofacial Research, and National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland, USA
*Experimental Medicine Section, Laboratory of Sensory Biology, National Institute of Dental and Craniofacial Research, and National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland, USA.
FASEB J. 2015 Oct;29(10):4374-83. doi: 10.1096/fj.15-273649. Epub 2015 Jul 6.
Islet antigen (IA)-2, IA-2β, and glutamate decarboxylase (GAD65) are major autoantigens in type 1 diabetes (T1D). Autoantibodies to these autoantigens appear years before disease onset and are widely used as predictive markers. Little is known, however, about what regulates the expression of these autoantigens. The present experiments were initiated to test the hypothesis that microRNAs (miRNAs) can target and affect the levels of these autoantigens. Bioinformatics was used to identify miRNAs predicted to target the mRNAs coding IA-2, IA-2β, and GAD65. RNA interference for the miRNA processing enzyme Dicer1 and individual miRNA mimics and inhibitors were used to confirm the effect in mouse islets and MIN6 cells. We show that the imprinted 14q32 miRNA cluster contains 56 miRNAs, 32 of which are predicted to target the mRNAs of T1D autoantigens and 12 of which are glucose-sensitive. Using miRNA mimics and inhibitors, we confirmed that at least 7 of these miRNAs modulate the mRNA levels of the T1D autoantigens. Dicer1 knockdown significantly reduced the mRNA levels of all 3 autoantigens, further confirming the importance of miRNAs in this regulation. We conclude that miRNAs are involved in regulating the expression of the major T1D autoantigens.
胰岛抗原(IA)-2、IA-2β和谷氨酸脱羧酶(GAD65)是1型糖尿病(T1D)的主要自身抗原。针对这些自身抗原的自身抗体在疾病发作前数年就会出现,并被广泛用作预测标志物。然而,对于调节这些自身抗原表达的因素知之甚少。开展本实验是为了验证微小RNA(miRNA)能够靶向并影响这些自身抗原水平的假说。利用生物信息学来鉴定预测可靶向编码IA-2、IA-2β和GAD65的mRNA的miRNA。对miRNA加工酶Dicer1进行RNA干扰以及使用单个miRNA模拟物和抑制剂来在小鼠胰岛和MIN6细胞中证实其作用。我们发现印记的14q32 miRNA簇包含56个miRNA,其中32个预测可靶向T1D自身抗原的mRNA,且其中12个对葡萄糖敏感。使用miRNA模拟物和抑制剂,我们证实这些miRNA中至少有7个可调节T1D自身抗原的mRNA水平。敲低Dicer1显著降低了所有3种自身抗原的mRNA水平,进一步证实了miRNA在这种调节中的重要性。我们得出结论,miRNA参与调节主要的T1D自身抗原的表达。